Cytokinetics Incorporated (CYTK) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Cytokinetics Incorporated, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$61.28
−0.39% today
Market cap
$8.6B
Overall quality
24/100
Kronos AI 30-day
+16.5%
8 of 8 simulated paths end higher
Cytokinetics Incorporated (CYTK) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $8.6B. It trades at $61.28, down 0.39% today. Its overall quality score is 24 out of 100, ranked against the whole US market. 15 analysts' average target of $110.93 implies +81.0% from today's price. Kronos AI's 30-day forecast is +16.5% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $110.93 |
| Low – high | $81.00 – $146.00 |
| Analysts | 15 |
| Upside to average | +81.0% |
Kronos AI 30-day forecast
| Expected close | $71.66 (+16.5%) |
| Likely range | +14.2% … +22.4% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 19 |
| Solvency | 39 |
| Growth | 15 |
| Overall | 24 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.